PL2662093T3 - Preparat tobramycyny - Google Patents

Preparat tobramycyny

Info

Publication number: PL2662093T3
Authority: PL; Poland
Prior art keywords: tobramycin formulation; tobramycin; formulation
Prior art date: 2012-05-09

Application number

PL13002039T

Other languages

English (en)

Inventor

David Higham

Kevin Hawkins

Original Assignee

Norton Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-09

Filing date

2013-04-18

Publication date

2015-06-30

2013-04-18 Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd

2015-06-30 Publication of PL2662093T3 publication Critical patent/PL2662093T3/pl

Links

238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title 1
229960000707 tobramycin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL13002039T 2012-05-09 2013-04-18 Preparat tobramycyny PL2662093T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261644700P	2012-05-09	2012-05-09
GBGB1208080.0A GB201208080D0 (en)	2012-05-09	2012-05-09	Tobramycin formulation
EP13002039.9A EP2662093B1 (en)	2012-05-09	2013-04-18	Tobramycin formulation

Publications (1)

Publication Number	Publication Date
PL2662093T3 true PL2662093T3 (pl)	2015-06-30

Family

ID=46396721

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13002039T PL2662093T3 (pl)	2012-05-09	2013-04-18	Preparat tobramycyny

Country Status (10)

Country	Link
US (1)	US9012416B2 (pl)
EP (1)	EP2662093B1 (pl)
BR (1)	BR112014027708A2 (pl)
DK (1)	DK2662093T3 (pl)
GB (1)	GB201208080D0 (pl)
PL (1)	PL2662093T3 (pl)
PT (1)	PT2662093E (pl)
TW (1)	TWI488656B (pl)
UY (1)	UY34796A (pl)
WO (1)	WO2013167233A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2565941A (en) *	2018-11-27	2019-02-27	Norton Healthcare Ltd	A process for preparing a formulation
CN113018443B (zh) *	2019-12-27	2022-09-13	海南斯达制药有限公司	治疗呼吸系统疾病的药物组合物及其制备方法
CN113952320B (zh) *	2021-09-18	2022-03-18	健康元药业集团股份有限公司	一种包含妥布霉素吸入溶液的药物组件及其用途
CN114796107B (zh) *	2022-05-09	2024-01-09	西藏邦臣药业集团有限公司	含二磷酸烟苷的硫酸妥布霉素注射液及其制备方法
CN120114382A (zh) *	2025-03-10	2025-06-10	湖南宝东制药集团有限公司	一种妥布霉素滴眼液制备工艺

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5508269A (en)	1994-10-19	1996-04-16	Pathogenesis Corporation	Aminoglycoside formulation for aerosolization
US20030143162A1 (en)	2001-05-18	2003-07-31	Speirs Robert John	Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
TR200401980T4 (tr)	2001-07-02	2004-09-21	Chiesi Farmaceutici S.P.A.	Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
NZ546821A (en)	2003-10-15	2009-04-30	Pari Pharma Gmbh	Liquid preparation containing tobramycin
EP1683526B1 (en)	2003-11-14	2012-04-11	Senju Pharmaceutical Co., Ltd.	Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
US20080227732A1 (en)	2005-05-13	2008-09-18	Venus Remedies Limited	Treatment and Control of Severe Infections Including Cystic Fibrosis
CN100341899C (zh)	2005-11-01	2007-10-10	中国药科大学	新的壳聚糖衍生物、其制法及其用于制备眼科制剂的用途
CN101129381B (zh)	2006-08-25	2012-02-01	天津和美生物技术有限公司	含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN1927201B (zh)	2006-08-25	2011-06-01	天津和美生物技术有限公司	含哌拉西林的抗生素复方
CN101129383B (zh)	2006-08-25	2014-04-02	天津和美生物技术有限公司	含氨基糖苷类抗生素的抗生素复方
WO2008130211A1 (es)	2007-04-20	2008-10-30	Serral, S.A. De C.V.	Solución dinámica, estequiométrica de soporte y de equilibrio inducido
US7795316B1 (en) *	2007-12-19	2010-09-14	Alcon Research, Ltd.	Topical ophthalmic compositions containing tobramycin and dexamethasone
EP2585037A1 (en)	2010-06-23	2013-05-01	Alcon Research, Ltd.	Topical ophthalmic suspensions containing tobramycin and dexamethasone

2012
- 2012-05-09 GB GBGB1208080.0A patent/GB201208080D0/en not_active Ceased
2013
- 2013-03-19 US US13/847,265 patent/US9012416B2/en active Active
- 2013-04-18 BR BR112014027708A patent/BR112014027708A2/pt not_active Application Discontinuation
- 2013-04-18 DK DK13002039.9T patent/DK2662093T3/en active
- 2013-04-18 EP EP13002039.9A patent/EP2662093B1/en active Active
- 2013-04-18 PT PT130020399T patent/PT2662093E/pt unknown
- 2013-04-18 PL PL13002039T patent/PL2662093T3/pl unknown
- 2013-04-18 WO PCT/EP2013/001156 patent/WO2013167233A1/en not_active Ceased
- 2013-05-08 UY UY0001034796A patent/UY34796A/es not_active Application Discontinuation
- 2013-05-09 TW TW102116586A patent/TWI488656B/zh active

Also Published As

Publication number	Publication date
US20130303475A1 (en)	2013-11-14
WO2013167233A1 (en)	2013-11-14
US9012416B2 (en)	2015-04-21
EP2662093B1 (en)	2015-01-14
UY34796A (es)	2014-11-28
GB201208080D0 (en)	2012-06-20
BR112014027708A2 (pt)	2017-07-18
TW201350138A (zh)	2013-12-16
PT2662093E (pt)	2015-02-17
EP2662093A1 (en)	2013-11-13
DK2662093T3 (en)	2015-02-16
TWI488656B (zh)	2015-06-21

Publication	Publication Date	Title
IL235966A0 (en)	2015-01-29	Antibody formulation
PL2802209T3 (pl)	2021-07-05	Preparaty do uszu
GB201217441D0 (en)	2012-11-14	Composition
GB201200707D0 (en)	2012-02-29	Composition
ZA201306000B (en)	2014-04-30	Stable formulation
EP2878295A4 (en)	2015-12-23	COMPOSITION
GB201218954D0 (en)	2012-12-05	Composition
GB201222275D0 (en)	2013-01-23	Composition
PT2662093E (pt)	2015-02-17	Formulação de tobramicina
GB201219657D0 (en)	2012-12-12	Composition
GB201206035D0 (en)	2012-05-16	Composition
EP2839835A4 (en)	2015-12-02	ENCAPSULATED FORMULATION
EP2910537A4 (en)	2016-06-29	AGENT COMPOSITION GENERATING GAS
GB201218195D0 (en)	2012-11-21	Composition
GB201209597D0 (en)	2012-07-11	Composition
GB201208133D0 (en)	2012-06-20	Composition
GB201311517D0 (en)	2013-08-14	Composition
GB201219383D0 (en)	2012-12-12	Composition
SI2662093T1 (sl)	2015-06-30	Formulacija tobramicina
GB201211247D0 (en)	2012-08-08	Improved formulation
GB201220595D0 (en)	2013-01-02	Keysafe application
AU2012905439A0 (en)	2013-01-10	Formulation
AU2012905410A0 (en)	2013-01-10	Formulation
GB201222922D0 (en)	2013-01-30	Topical formulation
GB201206178D0 (en)	2012-05-23	Formulations